The Texas Government has passed House Bill No. 1535, expanding medical use of low-THC cannabis by patients with certain medical conditions and the establishment of compassionate-use institutional review boards to evaluate and approve proposed research programs to study the medical use of low-THC cannabis in the treatment of certain patients. The law has come into effect on September 1, 2021.
The Act states that any patient suffering from any stage of cancer and battling post-traumatic stress disorder (PTSD) will be able to access physician-prescribed medical cannabis in Texas. The Act provides that Cancer and PTSD join other conditions eligible for medical cannabis including peripheral neuropathy, epilepsy, seizure disorders, autism, multiple sclerosis, spasticity, amyotrophic lateral sclerosis (ALS), as well as other neurodegenerative disorders such as Alzheimer’s, Parkinson’s, Huntington’s disease, chronic traumatic encephalopathy (CTE), etc.
*Tanvi Singh, Editorial Assistant has reported this brief.
